Lipomed

The Company

LIPOMED is a private Swiss Health Care Company. We are one of the leading companies for Reference Standards worldwide and specialized in the research, development and manufacturing of ethical pharmaceuticals and products for the treatment of rare diseases.

Since 1993 Lipomed is dedicated to providing products and services of outstanding quality and expertise.

We have our own GMP/GDP and ISO 9001 certified pharmaceutical production facilities in Arlesheim near Basel. We are also ISO/IEC 17025 accredited for testing of analytical reference standards and ISO Guide 34 accredited for the production of reference material.

Our innovative products are marketed and distributed with offices and partners in more than 50 countries around the world.

Quality / ISO

LIPOMED AG, Switzerland is GMP/GDP and ISO 9001 certified for production and distribution of Pharmaceuticals and ISO/IEC 17025 (ANAB Certificate No. AT-1760) accredited for testing of Analytical Reference Standards and ISO Guide 34 (ANAB Certificate No. AR-1761) accredited for Reference Material production. All products distributed by LIPOMED affiliates are manufactured by LIPOMED AG and distributed under protocols of LIPOMED AG.

Additionally, the Pharma Marketing of LIPOMED is certified according to the "Référentiel de certification de la visite médicale" by the French Authorities.

Products

Analytical Reference Standards

Lipomed AG’s Reference Standards include the following classes of substances, their deuterated analogues and metabolites, such as Glucuronides and Sulfates, which are available as calibrated ready to use (RTU) solutions, ready to use calibrated (RTU) powders and bulk powders in standard size packaging.

Lipomed Reference Standards are available as calibrated ready to use (RTU) solutions and as calibrated ready to use (RTU) powders filled in ampules or in 20 ml vials respectively.

Lipomed Reference Standards are also available as powders in standard pack sizes of 10 mg, 50 mg and 100 mg.

Lipomed Reference Standards are not to be used for any controlled preclinical or clinical studies.

New Products

#	Product	CAS
MAR-1699-FB	4-Methylaminorex	3568-94-3
DMR-1792-FB	cis-(±)-4,4’-Dimethylaminorex	1632031-39-0
FLV-1796-MA	Fluvoxamine.maleate	61718-82-9
TAP-1809-HC	Tapentadol-D3.HCl	1435782-38-9
VRP-1790-HC	Verapamil.HCl	152-11-4
LPR-1789-HC	Loperamide.HCl	34552-83-5
OXC-1751	Oxcarbazepine	28721-07-5
AMI-1788-HC	Amitriptyline-D3.HCl	342611-00-1
CPZ-1752-HC	Chlorpromazine.HCl	69-09-0
COC-207-HC	Cocaethylene.HCl	529-38-4

Please Contact us for more info

Επιστροφή